ENTITY
BGI Genomics

BGI Genomics (300676 CH)

37
Analysis
Health CareChina
BGI Genomics Co., Ltd offers researching and testing services. The Company provides deoxyribonucleic acid sequencing, food science, health care researching, cancer prevention, drug discovery, and DNA sequencing. BGI Genomics offers services to medical and scientific research institutions worldwide.
more
20 Apr 2020 12:47

BBI Life: Scheme Doc Out, IFA Ekes Out A Fair Opinion

Back on the 20 January, BBI Life Sciences (1035 HK), the largest supplier of DNA synthesis products in the PRC, announced a privatisation Offer by...

Logo
365 Views
Share
19 Oct 2018 07:34

AOBiome Therapeutics IPO: Hope for Natural Therapeutic Treatment

AOBiome Therapeutics, a U.S. based biotech company, is planning to raise up to USD 200 million in its listing on the Hong Kong Stock Exchange. In...

Logo
646 Views
Share
08 Nov 2017 20:24

Genomics as an Investment Theme

Genomics as an investment theme Costs of sequencing a human genome have fallen to less than $1,000 China leads the world in gene sequencing The...

Logo
335 Views
Share
bullishZai Lab Ltd
14 Sep 2017 17:41

Zai Lab IPO: Thoughts on Valuation, Risks and Upsides (Part 2)

In our first insight, we covered the company's background, particularly its management team and its product pipeline.In this insight, we will...

Logo
2k Views
Share
x